Genomatix Software GmbH today announced that it has achieved GeneChip-compatible TM status for several products with the Affymetrix Inc. (Nasdaq: AFFX) GeneChip® microarray platform and that it has ...

Genomatix Software GmbH has announced that it has achieved GeneChip-compatible™ status for several products with the Affymetrix Inc. GeneChip ® microarray platform and that it has joined Affymetrix ...

BioDiscovery, Inc. has announced that two of its products have achieved GeneChip-compatible™ status with the Affymetrix Inc. GeneChip microarray platform and that it has joined Affymetrix ...

The purpose of this study is to determine the feasibility of FFPE tissues of prostatic carcinoma for ‘cell type specific’ global gene expression evaluations. Of 18 patients utilized for microarray ...

SANTA CLARA, Calif.--(BUSINESS WIRE)--Affymetrix Inc. (Nasdaq:AFFX) today announced that the Genetic Association Information Network (GAIN) will use the recently launched Genome-Wide Human SNP Array 6 ...

Affymetrix, the Santa Clara, Calif.-based manufacturer of GeneChip ® microarrays, has developed a new device to create microarrays, according to a recently awarded patent. 1 The new technique replaces ...

Microarray technology has come of age as a powerful approach to revealing the genome and its dynamic expression through the application of gene-hybridization or gene-expression microarrays. While the ...